<TABLE> <S> <C>

<ARTICLE>                                  5
<LEGEND>
This schedule contains summary financial information extracted from the
financial statements included in the Form 10-QSB of Endogen, Inc. to which this
exhibit is a part and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
<RESTATED>
<CIK>                                      0000894020
<NAME>                                     Endogen, Inc.
<MULTIPLIER>                               1,000
<CURRENCY>                                 U.S. Dollars
       
<S>                                        <C>
<PERIOD-TYPE>                              9-mos
<FISCAL-YEAR-END>                          May-31-1997
<PERIOD-START>                             Jun-01-1996
<PERIOD-END>                               Feb-28-1997
<EXCHANGE-RATE>                                                    1.00
<CASH>                                                              387
<SECURITIES>                                                          0
<RECEIVABLES>                                                     1,754
<ALLOWANCES>                                                         20
<INVENTORY>                                                       1,739
<CURRENT-ASSETS>                                                  4,094
<PP&E>                                                            3,399
<DEPRECIATION>                                                      997
<TOTAL-ASSETS>                                                    7,266
<CURRENT-LIABILITIES>                                             1,799
<BONDS>                                                               0
<PREFERRED-MANDATORY>                                                 0
<PREFERRED>                                                           0
<COMMON>                                                             34
<OTHER-SE>                                                        5,184
<TOTAL-LIABILITY-AND-EQUITY>                                      7,266
<SALES>                                                           7,183
<TOTAL-REVENUES>                                                  7,183
<CGS>                                                             2,485
<TOTAL-COSTS>                                                     6,544
<OTHER-EXPENSES>                                                      0
<LOSS-PROVISION>                                                      0
<INTEREST-EXPENSE>                                                  157
<INCOME-PRETAX>                                                     482
<INCOME-TAX>                                                         75
<INCOME-CONTINUING>                                                 407
<DISCONTINUED>                                                        0
<EXTRAORDINARY>                                                       0
<CHANGES>                                                             0
<NET-INCOME>                                                        407
<EPS-PRIMARY>                                                       .14
<EPS-DILUTED>                                                       .12
        

</TABLE>